Zydus Wellness

₹1706.4 7.5 | 0.4%

WEBSITE BSE:531335 NSE : ZYDUS WELL 10 May, 16:01

Market Cap ₹10858 Cr.

Stock P/E 41.4

P/B 2.1

Current Price ₹1706.4

Book Value ₹ 818.3

Face Value 10

52W High ₹1734

Dividend Yield 0.29%

52W Low ₹ 1425

Edit Ratio

Zydus Wellness Research see more...

EQUITY RESEARCH: ZYDUS WELLNESS LTD.

Overview Inc. Year: 1994Industry: Consumer Food

Zydus Wellness Ltd is an integrated consumer corporation. The Company is engaged within the improvement, manufacturing, advertising and marketing and distribution of health and well-being merchandise. The Company's products include table margarine. Its product portfolio includes brands, along with Sugar Free, Everyuth and Nutralite. Its Sugar Free logo portfolio consists of Sugar Free Gold, which is used as sugar alternative in arrangements, consisting of tea, coffee and fruit juices, and Sugar Free Natura, that is utilized in arrangements, together with cakes, chocolates, blended fruit custard and ice cream. It offers various speciality skincare products below the brand name of Everyuth Naturals, which consists face wash, facial mask (peel off, packs), scrubs, sun blocks, winter care (body lotion and cream), purifier and toner, soaps and men skin care (face washes, sun block, moisturizer and scrub). The Company beneath Nutralite brand gives a table spread, which has poly unsaturated fatty acids and mono unsaturated fatty acids.

Zydus Wellness Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Zydus Wellness Quarterly Results

#(Fig in Cr.)	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
Net Sales	384	388	640	696	429	416	713	702	440	403
Other Income	3	3	2	2	1	1	1	2	4	3
Total Income	387	391	642	698	431	417	714	705	444	407
Total Expenditure	353	356	498	548	413	388	568	586	423	391
Operating Profit	34	35	143	150	18	29	145	119	21	16
Interest	7	6	6	4	3	4	5	5	7	6
Depreciation	6	6	6	6	6	6	7	6	6	6
Exceptional Income / Expenses	0	0	0	-3	0	0	0	-14	0	0
Profit Before Tax	21	23	131	137	8	19	133	93	9	4
Provision for Tax	-0	-1	-2	0	-0	-0	-19	-17	3	3
Profit After Tax	21	23	133	137	9	20	152	110	6	0
Adjustments	0	0	0	0	0	0	-7	0	0	0
Profit After Adjustments	21	23	133	137	9	20	145	110	6	0
Adjusted Earnings Per Share	3.4	3.7	20.9	21.5	1.3	3.1	22.8	17.4	0.9	0

Zydus Wellness Profit & Loss

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	TTM
Net Sales	388	404	431	397	431	513	843	1767	1867	2009	2255	2258
Other Income	16	19	28	32	33	35	39	11	9	13	5	10
Total Income	404	423	458	429	463	548	882	1778	1876	2022	2260	2270
Total Expenditure	291	314	331	305	332	387	658	1446	1522	1667	1918	1968
Operating Profit	112	108	128	124	132	160	224	332	353	355	342	301
Interest	0	0	0	0	1	2	30	140	84	26	16	23
Depreciation	5	5	8	7	7	9	13	26	25	24	25	25
Exceptional Income / Expenses	0	0	0	0	0	0	-10	-44	-132	0	-10	-14
Profit Before Tax	108	104	120	117	124	150	171	121	112	306	291	239
Provision for Tax	9	5	9	12	13	13	-1	-20	-7	-3	-20	-30
Profit After Tax	99	98	111	105	111	137	171	142	119	309	310	268
Adjustments	-2	-2	-2	-2	-2	-3	-2	0	0	0	0	-7
Profit After Adjustments	97	96	109	103	109	134	169	142	119	309	310	261
Adjusted Earnings Per Share	24.9	24.7	27.9	26.4	27.9	34.3	29.3	24.6	18.7	48.5	48.8	41.1

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	12%	8%	34%	19%
Operating Profit CAGR	-4%	1%	16%	12%
PAT CAGR	0%	30%	18%	12%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	12%	-7%	6%	13%
ROE Average	6%	5%	6%	19%
ROCE Average	6%	5%	6%	20%

Zydus Wellness Balance Sheet

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Shareholder's Funds	257	326	406	479	557	691	3386	3461	4568	4844	5123
Minority's Interest	3	5	7	9	11	13	0	0	0	0	0
Borrowings	0	0	0	0	0	0	1500	1500	313	63	0
Other Non-Current Liabilities	5	6	5	5	-55	-71	-77	-107	-111	-23	-43
Total Current Liabilities	85	89	90	75	113	122	546	615	771	767	692
Total Liabilities	349	425	508	568	626	755	5356	5469	5540	5651	5772
Fixed Assets	94	95	84	82	103	104	4567	4674	4667	4710	4732
Other Non-Current Assets	13	26	38	53	7	4	90	20	26	127	131
Total Current Assets	241	303	385	433	516	647	698	776	847	814	908
Total Assets	349	425	508	568	626	755	5356	5469	5540	5651	5772

Zydus Wellness Cash Flow

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Opening Cash & Cash Equivalents	132	191	268	19	23	21	30	210	193	253	170
Cash Flow from Operating Activities	69	91	69	90	77	69	149	259	287	237	92
Cash Flow from Investing Activities	13	13	29	-28	-72	-59	-4162	-17	-10	-86	-85
Cash Flow from Financing Activities	-23	-27	-27	-58	-6	-2	4052	-260	-216	-234	-138
Net Cash Inflow / Outflow	59	77	71	4	-1	8	39	-18	60	-83	-132
Closing Cash & Cash Equivalent	191	268	339	23	21	30	138	193	253	170	38

Zydus Wellness Ratios

#	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Earnings Per Share (Rs)	24.86	24.69	27.89	26.43	27.89	34.27	29.33	24.58	18.66	48.54	48.78
CEPS(Rs)	26.5	26.35	30.43	28.68	30.31	37.21	31.87	29.16	22.61	52.25	52.71
DPS(Rs)	6	6	6	6.5	6.5	8	5	5	5	5	5
Book NAV/Share(Rs)	65.66	83.33	103.93	122.49	142.61	176.91	587.28	600.18	717.87	761.28	805.07
Core EBITDA Margin(%)	23.52	20.79	22.06	21.44	21.42	24.04	21.93	16.63	17.11	15.91	13.95
EBIT Margin(%)	26.26	24.1	26.44	27.45	26.93	29.06	23.82	13.53	9.74	15.4	12.7
Pre Tax Margin(%)	26.24	24.07	26.41	27.42	26.81	28.73	20.25	6.28	5.57	14.22	12.03
PAT Margin (%)	24.1	22.84	24.54	24.7	24.06	26.19	20.32	7.34	5.9	14.35	12.84
Cash Profit Margin (%)	25.2	23.92	26.24	26.3	25.61	27.9	21.8	8.71	7.15	15.45	13.87
ROA(%)	32.13	25.4	23.83	19.57	18.64	19.77	5.6	2.62	2.16	5.52	5.43
ROE(%)	44.67	33.78	30.39	23.79	21.49	21.87	8.4	4.14	2.96	6.56	6.23
ROCE(%)	48.67	35.65	32.74	26.44	23.48	23.33	7.08	5.26	3.88	6.41	5.77
Receivable days	0.96	1.73	1.66	1.81	2.68	4.48	22.69	20.25	19.26	20.06	26.43
Inventory Days	30.32	29.17	21.73	21.41	22.05	23.44	58.06	49.65	59.57	61.58	61.83
Payable days	185.83	141.36	219.01	256.06	257.37	234.51	397.09	210.15	203.71	149.46	107.91
PER(x)	17.47	20.15	36.41	28.12	31.16	34.23	44.26	52.77	105.73	30.92	31.78
Price/Book(x)	6.61	5.97	9.77	6.07	6.1	6.63	2.21	2.16	2.75	1.97	1.93
Dividend Yield(%)	1.38	1.21	0.59	0.87	0.75	0.68	0.39	0.39	0.25	0.33	0.32
EV/Net Sales(x)	3.88	4.16	8.42	6.55	6.92	8.18	10.55	5.05	6.88	4.86	4.49
EV/Core EBITDA(x)	13.4	15.5	28.45	21	22.63	26.16	39.75	26.87	36.37	27.48	29.58
Net Sales Growth(%)	15.22	4.03	6.71	-7.9	8.54	19.06	64.41	109.63	5.65	7.63	12.23
EBIT Growth(%)	30.97	-3.85	15.44	-2.37	6.51	21.59	32.54	30.12	-24.95	69.14	-7.42
PAT Growth(%)	44.38	-0.73	13.06	-5.32	5.74	22.67	25.44	-17.24	-16.22	160.14	0.49
EPS Growth(%)	43.48	-0.68	12.96	-5.22	5.54	22.87	-14.41	-16.21	-24.08	160.15	0.49
Debt/Equity(x)	0	0	0	0	0.04	0.04	0.46	0.44	0.12	0.08	0.06
Current Ratio(x)	2.84	3.41	4.29	5.74	4.55	5.32	1.28	1.26	1.1	1.06	1.31
Quick Ratio(x)	2.36	3.1	4	5.42	4.27	5.03	0.85	0.79	0.63	0.59	0.65
Interest Cover(x)	1079.1	798.15	921.38	835.29	226.45	89.08	6.67	1.87	2.34	13	19.09
Total Debt/Mcap(x)	0	0	0	0	0.01	0.01	0.21	0.2	0.04	0.04	0.03

Zydus Wellness Shareholding Pattern

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	64.82	64.82	65.14	65.35	65.35	66.45	67.1	68.54	69.15	69.62
FII	3.39	2.56	2.38	3.24	3.83	3.87	3.23	3.42	3.25	3.26
DII	24.81	25.1	25.11	23.79	23.35	22.18	22.05	20.23	19.68	19.41
Public	6.99	7.51	7.37	7.62	7.47	7.5	7.62	7.81	7.93	7.71
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	4.12	4.12	4.14	4.16	4.16	4.23	4.27	4.36	4.4	4.43
FII	0.22	0.16	0.15	0.21	0.24	0.25	0.21	0.22	0.21	0.21
DII	1.58	1.6	1.6	1.51	1.49	1.41	1.4	1.29	1.25	1.24
Public	0.44	0.48	0.47	0.48	0.48	0.48	0.48	0.5	0.5	0.49
Others	0	0	0	0	0	0	0	0	0	0
Total	6.36	6.36	6.36	6.36	6.36	6.36	6.36	6.36	6.36	6.36

Pros

Debtor days have improved from 149.46 to 107.91days.
Company has reduced debt.
Company is almost debt free.

Cons

Company has a low return on equity of 5% over the last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Zydus Wellness News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

Current Price: 550/-

Empire Spices and Foods ltd

IPO

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Zydus Wellness

Add Watchlist

Zydus Wellness Research see more...

Overview Inc. Year: 1994Industry: Consumer Food

Zydus Wellness Share Price

Alert Data

Quarterly Price

Peer Comparison

Zydus Wellness Quarterly Results

Zydus Wellness Profit & Loss

Growth Rates

Zydus Wellness Balance Sheet

Zydus Wellness Cash Flow

Zydus Wellness Ratios

Zydus Wellness Shareholding Pattern

Zydus Wellness News

Top Unlisted Companies & InstaBuy Companies

Empire Spices and Foods ltd

IPO

Stocx: India's #1 Marketplace to Find Your Winning Stock

Please Login!

Error!